Letter: Second malignancies in treated Hodgkin's patients and splenectomy.
D006689:Hodgkin Disease / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007165:Immunosuppression Therapy; D007938:Leukemia / Q000209:etiology; D009378:Neoplasms, Multiple Primary / Q000209:etiology*; D013154:Spleen / Q000276:immunology; D013156:Splenectomy / Q000009:adverse effects*